Newsroom

CHARLOTTE, N.C.--(BUSINESS WIRE)--Krispy Kreme® is celebrating peak blueberry season with the new, limited-time Original Glazed® Blueberry Flavored Doughnut – a berry delicious twist on the iconic Original Glazed® that captures the sweetest moments of summer in every bite. Available for four days only – Thursday through Sunday (July 23-26) – this irresistible treat features Krispy Kreme's melt-in-your-mouth Original Glazed® doughnut made with blueberry-flavored dough, delivering a vibrant, frui...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ZoomInfo Technologies Inc. (NASDAQ: GTM) securities between November 3, 2025 and May 11, 2026. ZoomInfo Technologies Inc., together with its subsidiaries, provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally.For more information, submit...

PLEASANTON, Calif.--(BUSINESS WIRE)--In collaboration with Stanford Medicine, The BRAIN Foundation launched the Aurora Research Network, backing the effort with an initial $2M pledge....

IRVING, Texas--(BUSINESS WIRE)--American Beacon today announced the appointment of William (“Bill”) MacGregor as Deputy General Counsel....

باريس--(BUSINESS WIRE)--قبل بضعة أشهر من انطلاق SIAL Paris 2026 (في الفترة من 17 إلى 21 أكتوبر، في Paris Nord Villepinte)، أماط المعرض التجاري اللثام عن نتائج تقريره الجديد SIAL Insights 2026، وهو تحليل دولي يحدد عشرة اتجاهات رئيسية من المتوقع أن تُحدث تغييرات دائمة تطول أسواق الأغذية وسلوك المستهلكين.أُعدّ التقرير بالاعتماد على بيانات حصرية من Kantar Food 360™‎ وCircana وProtéinesXTC، ويسلّط الضوء على منهج تجريبي قوامه التخصيص والفعالية في مجال الأغذية، كما يكشف عن المفاضلات الجديدة التي يجريها...

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (OTC Pink: BURU), a next-generation dual-use Defense & Security integrated platform company, today announced it has repaid in full the approximately $15.5 million remaining principal of its December 2025 debenture and the entire $1.25 million aggregate principal of the subordinated convertible notes issued in connection with its acquisition of Lyocon S.r.l. ("Lyocon") — approximately $16.75 million of principal obligations extinguished within days of cl...

[NEW YORK--(BUSINESS WIRE)--Harlow Payments, the premier payments processing solution helping businesses simplify financial operations, today announced the appointment of payments industry veteran Ray Sidhom as Executive Chairman. As Executive Chairman, Sidhom will work alongside Harlow's leadership team to help guide the company's long-term strategy and continued growth as it expands its suite of offerings and partnerships. "Ray's track record speaks for itself, and we’re thrilled to have him...

WASHINGTON--(BUSINESS WIRE)--Avenue Growth Partners (“Avenue”), an early growth equity firm backing category-defining vertical technology companies, today announced the close of its second fund, Avenue Growth Partners Fund II, at $155 million. The fund, which follows Avenue’s $83 million debut fund, was significantly oversubscribed and closed at its hard cap. Fund II has attracted a diverse base of institutional capital, with limited partners spanning public pensions, private foundations, funds...

FOSTER CITY, Calif. & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the detailed outcomes from the Phase 3 ISLEND-1 and ISLEND-2 trials will be presented for the first time at the 26th International AIDS Conference (AIDS 2026). The primary endpoint results at Week 48 showed that the investigational once-weekly oral single-tablet HIV treatment regimen of islatravir 2 mg/lenacap...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 26th International AIDS Conference (AIDS 2026) taking place in Rio de Janeiro, Brazil, from July 26-31. As a leader in HIV innovation, Gilead will share new scientific data from its HIV research and development programs and provide updates on its strategic initiatives and key collaborations. The data to be presented, together with Gilead-led symposia and community forums,...